Adjunct to diet and exercise in type 2 diabetes mellitus, as monotherapy or combination therapy.
5mg once daily.
Dipeptidyl peptidase-4 inhibitor.
Not for the treatment of type 1 diabetes or diabetic ketoacidosis. Pregnancy (Cat.B). Nursing mothers.
Antagonized by strong P-gp or CYP3A4 inducers (eg, rifampin); consider alternatives to linagliptin if used in combination. May need lower dose of concomitant sulfonylurea or insulin to reduce risk of hypoglycemia.
Nasopharyngitis, hypoglycemia, arthralgia, back pain, headache; hypersensitivity reactions (eg, urticaria, angioedema, localized skin exfoliation, bronchial hyperreactivity), myalgia, pancreatitis.
Enterohepatic (80%), renal (5%).
Tabs—30, 90, 1000